Bcl-2 inhibitor WEHI539, Purity ≥98%

Synonym: 1431866-33-9; WEHI-539; 5-[3-[4-(Aminomethyl)phenoxy]propyl]-2-[(8E)-8-(1,3-benzothiazol-2-Ylhydrazinylidene)-6,7-dihydro-5H-naphthalen-2-Yl]-1,3-thiazole-4-carboxylic acid; Bcl-2 inhibitor

CAS Number: 1431866-33-9
Compound CID: 71297207

Product Size

5 mg; 10 mg; 25 mg; 50 mg; 100 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

WEHI539 specifically inhibits the function of the anti-apoptotic proteins, thereby promoting apoptosis in cancer cells.

Molecular Weight

583.72

Molecular Formula

C₃₁H₂₉N₅O₃S₂

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Stability

The product is stable for three years when stored at the recommended temperature in lyophilized powder.

Applications

WEHI539 serves as a research tool for selectively inhibiting Bcl-XL to study its role in cell survival and apoptosis.

Storage

Store at -20ºC.